By Iain Gilbert
Date: Monday 15 Sep 2025
(Sharecast News) - Medical diagnostics firm Renalytix said on Monday that it has struck a definitive agreement with Tempus AI to accelerate the adoption of its kidneyintelX.dkd test to support early-stage risk assessment in chronic kidney disease, slow progression, and improve patient outcomes.
Holding(s) in Company | 16-Sep-2025 | 18:26 | RNS |
IB Enters Agreement with MedImageMetric | 16-Sep-2025 | 15:49 | RNS |
Notice of Preliminary Results | 16-Sep-2025 | 07:00 | RNS |
Notice of Results | 16-Sep-2025 | 07:00 | RNS |
Holding(s) in Company | 16-Sep-2025 | 07:00 | RNS |
Investment Column:Consort Medical | 02-Dec-2011 | The Independent |
Investment Column:Lidco | 27-Oct-2011 | The Independent |
FTSE live: London steady; Burberry down | 14-Mar-2011 | Daily Mail |
FTSE close: Tesco up; Mining shares surge | 08-Dec-2010 | Daily Mail |
Investment Column : Lidco | 27-Oct-2010 | The Independent |
Price | 9,646.67 |
Closing Price Change | 0.00 |
% Change | 0.00 % |
16-Sep-25 Close | 9,646.67 |
You are here: research